Screening compound: InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3

Screening compound: InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3
Screening compound: InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S895-1119

Molecular Formula

C21H34N4O (C21 H34 N4 O)

Compound Name

1'-cyclohexanecarbonyl-3-(propan-2-yl)-5,6,8,9-tetrahydrospiro[[1,2,4]triazolo[4,3-a]azepine-7,4'-piperidine]

IUPAC name

1'-cyclohexanecarbonyl-3-(propan-2-yl)-5689-tetrahydrospiro[[124]triazolo[43-a]azepine-74'-piperidine]

SMILES

CC(C)c1nnc2n1CCC(CC1)(CCN1C(C1CCCCC1)=O)CC2

MDL Number (MFCD)

InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Ion Channels Focused Library (26372 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Nervous system
  • Cardiovascular
Targets:
  • Ion Channels

References: we are preparing a list of scientific research reports with InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3?
Check Price and Availability of InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H34N4O/c1-16(2)19-23-22-18-8-9-21(12-15-25(18)19)10-13-24(14-11-21)20(26)17-6-4-3-5-7-17/h16-17H,3-15H2,1-2H3 available by request